Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement.
Roy A, Maiti A, Sinha A, Baidya A, Basu AK, Sarkar D, Sanyal D, Biswas D, Maisnam I, Pandit K, Raychaudhuri M, Sengupta N, Chakraborty PP, Mukhopadhyay P, Raychaudhuri P, Sahana PK, Chatterjee P, Bhattacharjee R, Dasgupta R, Saraogi RK, Pal SK, Mukhopadhyay S, Mukhopadhyay S, Goswami S, Chowdhury S, Ghosh S; Working Group of the Endocrine Society of Bengal.
Roy A, et al. Among authors: chakraborty pp.
Diabetes Ther. 2020 Dec;11(12):2791-2827. doi: 10.1007/s13300-020-00921-y. Epub 2020 Oct 6.
Diabetes Ther. 2020.
PMID: 33025397
Free PMC article.
Review.